July 26, 2022
EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell and gene therapy and cell line development research. Since acquiring the Beacon Platform in October 2021, Otsuka Pharmaceutical scientists have [...]
lino Biotech Expands Board of Directors
July 26, 2022
Dr. Matthias Essenpreis, Chief Technology Officer at Roche Diagnostics, complements the team of lino Biotech´s board members ZURICH -- lino Biotech AG, a spin-out from Roche Diagnostics that has developed a reagent-free method for measuring molecular interactions in living cells or crude biological samples, welcomes Dr. Matthias Essenpreis as its new board member. With his [...]
ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
July 26, 2022
License allows Lepton, with their proprietary Castling Technology, to develop and commercialize products and services using CRISPR/Cas9 technology Dublin, Ireland and Zikhron Ya’akov, Israel: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD (‘Lepton”). This is a non-exclusive licensing agreement granting Lepton access to the ERS CRISPR/Cas9 patent [...]
Agilent ESG Report Highlights Plans and Progress to Ensure Future Sustainable Growth
July 25, 2022
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today released its inaugural Environmental, Social, and Governance (ESG) report, including the company’s first TCFD climate risk report; details on its commitment to reach net-zero greenhouse gas emissions by 2050; and progress on cultivating a diverse, inclusive, and engaged workforce. “The tenets of ESG have always been [...]
Argonaut Manufacturing Services Launches BioFuse Sample Prep Device, Simplifies Molecular Assays
July 25, 2022
Carlsbad, CA – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life sciences, and molecular diagnostics industries, today announced the launch of BioFuseTM* Sample Prep device. BioFuse is a disposable cartridge solution that enables seamless integration of lyophilized reagents, sample filtration, and removal of pipetting steps to greatly simplify complex assay workflows. BioFuse requires no [...]
Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer
July 25, 2022
EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO), effective immediately. "We are excited to have Mehul join Berkeley Lights and further strengthen our executive leadership team," said Siddhartha Kadia, Ph.D., chief executive officer of Berkeley Lights. "Mehul [...]
New Product Alert: Introducing the New Mini 16™ Ultra-Fast Portable qPCR Machine From Four E’s USA
July 25, 2022
The Tiny, Portable, and Economical Mini 16™ Ultra-Fast Portable qPCR Machine is designed for Point-of-Care Testing, Research, and Veterinary Applications PRINCETON, N.J. - Introducing the new Mini 16™ ultra-fast portable qPCR machine from Four E's USA. A miniaturized real time PCR device with 16 sample wells. Polymerase chain reaction (PCR) is a revolutionary laboratory method that [...]
July 25, 2022
Shimadzu Corporation is participating in the project “Creating a System for Maintaining the Mental Health of Working People—Preventing Depression and Supporting Return to Work—” being undertaken by Kyushu University (Fukuoka City; President: Tatsuro Ishibashi) and Human Metabolome Technologies Inc. (Head Office: Tsuruoka City, Yamagata Prefecture; Representative Director and President: Katsuhito Hashizume; HMT). Kyushu University Hospital [...]
Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA
July 25, 2022
KKR and OMX Ventures lead $55 million seed funding round Replay’s genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform Company is led and supported by a world-class team [...]
July 25, 2022
Tokyo - Konica Minolta, Inc. (Konica Minolta) is pleased to announce that on July 13, its group company, Konica Minolta REALM, Inc., obtained manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for its GenMineTOP Cancer Genome Profiling System, which can analyze both DNA and RNA genetic information in Japan. This system [...]

